<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01542385</url>
  </required_header>
  <id_info>
    <org_study_id>PRIMACY</org_study_id>
    <nct_id>NCT01542385</nct_id>
  </id_info>
  <brief_title>Primary Reperfusion Secondary Stenting Trial</brief_title>
  <acronym>PRIMACY</acronym>
  <official_title>Immediate vs. Delayed Stenting After Primary Percutaneous Reperfusion in ST Elevation Myocardial Infarction</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Montreal Heart Institute</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Montreal Heart Institute</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this research project is to improve how we treat heart attacks. The study will&#xD;
      assess whether it might not be better to wait a few hours before implanting the coronary&#xD;
      stent into the coronary artery rather than implanting it immediately, in order to allow the&#xD;
      drugs to completely dissolve the clot. This might help to reduce the risks of the clot&#xD;
      migrating and damaging the heart. By delaying coronary stent implantation, we hope to be able&#xD;
      to reduce the size of the infarction and reduce the risk of suffering from heart failure&#xD;
      following a heart attack.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The PRIMACY trial seeks to assess whether a strategy of delayed stent implantation combined&#xD;
      with adjunctive anticoagulation is superior to immediate stent implantation at improving&#xD;
      cardiovascular outcomes in patients with mechanically reperfused ST-elevation Myocardial&#xD;
      Infarction (STEMI). The investigators hypothesize that delayed stent implantation combined&#xD;
      with systemic anticoagulation and maximal antiplatelet therapy will reduce the combined&#xD;
      occurrence of cardiac death, non-fatal myocardial infarction, congestive heart failure, or&#xD;
      unplanned target vessel revascularization over a 9-month period.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>April 2014</start_date>
  <completion_date type="Actual">August 2019</completion_date>
  <primary_completion_date type="Actual">May 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>The combined occurence of cardiac death, non-fatal myocardial infarction, congestive heart failure, and urgent target vessel revascularization</measure>
    <time_frame>9 months</time_frame>
    <description>As defined by standardized definitions</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Major bleeding</measure>
    <time_frame>9 months</time_frame>
    <description>As defined by the Bleeding Academic Research Consortium (BARC).</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">307</enrollment>
  <condition>ST-elevation Myocardial Infarction</condition>
  <arm_group>
    <arm_group_label>Immediate stenting</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>the stent selection (bare metal vs drug eluting) and implantation will be performed as recommended by current practice guidelines.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Delayed stenting</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>participants randomised to delayed stenting will be treated with GPIIb-IIIa inhibitors for 12-18 hours after reperfusion followed by anticoagulation for until the control angiogram, expected no sooner than 18-24 hours after the index reperfusion.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Stent</intervention_name>
    <description>Percutaneous coronary intervention: reperfusion with a thrombectomy catheter or a small balloon angioplasty catheter, followed by coronary stenting</description>
    <arm_group_label>Delayed stenting</arm_group_label>
    <arm_group_label>Immediate stenting</arm_group_label>
    <other_name>Thrombectomy catheter</other_name>
    <other_name>Balloon angioplasty catheter</other_name>
    <other_name>Coronary stent</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          1. Age between 18 and 80 years;&#xD;
&#xD;
          2. STEMI, presenting within 12 hours of symptoms onset, and persisting for more than 20&#xD;
             minutes;&#xD;
&#xD;
          3. ECG that fulfills any of the following criteria: ≥ 2 mm ST elevation in two anterior&#xD;
             or lateral leads; or ≥ 1 mm ST elevation in two inferior leads; or new left bundle&#xD;
             branch block (LBBB) with at least 1 mm concordant ST elevation;&#xD;
&#xD;
          4. Infarct-related artery with TIMI flow 0 or 1 at baseline angiogram;&#xD;
&#xD;
          5. Successful reperfusion (TIMI 2-3 flow), either spontaneously or after wire passage,&#xD;
             thrombectomy, small size (≤ 2.0mm) angioplasty catheter, and persisting for more than&#xD;
             10 minutes;&#xD;
&#xD;
          6. Infarct related artery with a diameter above 2.5 mm.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. Prior STEMI in the qualifying coronary artery;&#xD;
&#xD;
          2. Coronary dissection following reperfusion;&#xD;
&#xD;
          3. STEMI caused by acute stent thrombosis or a venous or arterial bypass graft occlusion;&#xD;
&#xD;
          4. Significant left main disease, as determined by angiography (≥ 50%) or other imaging&#xD;
             technologies;&#xD;
&#xD;
          5. Cardiac condition requiring emergent or urgent surgical repair;&#xD;
&#xD;
          6. Failed thrombolysis and rescue PCI;&#xD;
&#xD;
          7. High risk of bleeding;&#xD;
&#xD;
          8. Contraindication to either ticagrelor or GpIIb/IIIa inhibitors;&#xD;
&#xD;
          9. STEMI with Killip III-IV or cardiogenic shock or presenting as sudden death,&#xD;
             ventricular fibrillation, or sustained ventricular tachycardia;&#xD;
&#xD;
         10. Women who are pregnant or breastfeeding;&#xD;
&#xD;
         11. Creatinine clearance &lt; 20 ml/min;&#xD;
&#xD;
         12. Other contraindication to PCI;&#xD;
&#xD;
         13. Participation with another investigational drug or investigational device study within&#xD;
             30 days prior to randomization (participation to registries is allowed);&#xD;
&#xD;
         14. Any condition that in the opinion of the investigator would preclude compliance with&#xD;
             the study protocol.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Marc E Jolicoeur, MD MSc MHS</last_name>
    <role>Study Chair</role>
    <affiliation>Montreal Heart Institute, Université de Montréal</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Nandini Dendukuri, PhD</last_name>
    <role>Study Director</role>
    <affiliation>Centre for Outcomes Research, McGill University Health Centre - Research Institute</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Loic Belle, MD</last_name>
    <role>Study Director</role>
    <affiliation>Hospital of Annecy, Centre Hospitalier Annecy Genevois, Annecy, France</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Montreal Heart Institute</name>
      <address>
        <city>Montreal</city>
        <state>Quebec</state>
        <zip>H1T 1C8</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>CHUM-Hôtel-Dieu de Montréal</name>
      <address>
        <city>Montreal</city>
        <state>Quebec</state>
        <zip>H2W 1T8</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hôpital du Sacré Cœur de Montréal</name>
      <address>
        <city>Montreal</city>
        <state>Quebec</state>
        <zip>H4J 1C5</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Centre Hospitalier Régional de Lanaudière</name>
      <address>
        <city>St-Charles-Borromée</city>
        <state>Quebec</state>
        <zip>J6E 6J2</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>CHR CSSS de Trois Rivières</name>
      <address>
        <city>Trois Rivières</city>
        <state>Quebec</state>
        <zip>G8Z 3R9</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>CH de Bastia</name>
      <address>
        <city>Bastia</city>
        <zip>20200</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>CH de Cannes</name>
      <address>
        <city>Cannes</city>
        <zip>06401</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>CHU de Clermont-Ferrand</name>
      <address>
        <city>Clermont-Ferrand</city>
        <zip>63000</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hôpital Louis-Pasteur</name>
      <address>
        <city>Le Coudray</city>
        <zip>28360</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>HCL Hopital Croix Rousse</name>
      <address>
        <city>Lyon</city>
        <zip>69317</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>CH Annecy Genevois</name>
      <address>
        <city>Metz-Tessy</city>
        <zip>74370</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Ch de Montpellier-Hôpital A. de Villneuve</name>
      <address>
        <city>Montpellier</city>
        <zip>34295</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>CH de Nimes</name>
      <address>
        <city>Nimes</city>
        <zip>30029</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>CH de Pau</name>
      <address>
        <city>Pau</city>
        <zip>64000</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>CHU de Toulouse-Hôpital Rangueil</name>
      <address>
        <city>Toulouse</city>
        <zip>31059</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>CH de Vichy</name>
      <address>
        <city>Vichy</city>
        <zip>03200</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Canada</country>
    <country>France</country>
  </location_countries>
  <link>
    <url>http://www.onlinecjc.ca/article/S0828-282X(11)00400-4/fulltext</url>
    <description>Canadian Journal of Cardiology Editorial</description>
  </link>
  <link>
    <url>https://www.onlinecjc.ca/article/S0828-282X(20)30055-6/abstract</url>
    <description>Methods paper</description>
  </link>
  <verification_date>August 2020</verification_date>
  <study_first_submitted>February 16, 2012</study_first_submitted>
  <study_first_submitted_qc>March 1, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 2, 2012</study_first_posted>
  <last_update_submitted>August 3, 2020</last_update_submitted>
  <last_update_submitted_qc>August 3, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">August 5, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Montreal Heart Institute</investigator_affiliation>
    <investigator_full_name>Marc Jolicoeur</investigator_full_name>
    <investigator_title>E. Marc Jolicoeur, MD MSc MHS FRCP-C FACC</investigator_title>
  </responsible_party>
  <keyword>Delayed stenting</keyword>
  <keyword>Deferred stenting</keyword>
  <keyword>Late stenting</keyword>
  <keyword>postponed stenting</keyword>
  <keyword>Thrombectomy</keyword>
  <keyword>Percutaneous coronary intervention</keyword>
  <keyword>PCI</keyword>
  <keyword>Angioplasty</keyword>
  <keyword>STEMI</keyword>
  <keyword>acute myocardial infarction</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Myocardial Infarction</mesh_term>
    <mesh_term>ST Elevation Myocardial Infarction</mesh_term>
    <mesh_term>Infarction</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

